UiPath, Inc.: Form 10-Q for the period ended Oct 31, 2021
Filed with the SEC on Dec 10, 2021 and accepted by EDGAR at Dec 9, 2021, 18:40 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-08-01 to 2021-10-31 | $220.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2021-02-01 to 2021-10-31 | $602.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-08-01 to 2021-10-31 | $43.1m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2021-02-01 to 2021-10-31 | $127.7m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2021-08-01 to 2021-10-31 | $177.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2021-02-01 to 2021-10-31 | $474.9m | us-gaap:GrossProfit |
| Research and development | 3 months2021-08-01 to 2021-10-31 | $61.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2021-02-01 to 2021-10-31 | $212.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2021-08-01 to 2021-10-31 | −$116.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-02-01 to 2021-10-31 | −$450.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2021-08-01 to 2021-10-31 | $3.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2021-02-01 to 2021-10-31 | $6.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-08-01 to 2021-10-31 | −$122.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-02-01 to 2021-10-31 | −$462.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-08-01 to 2021-10-31 | −$0.23 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2021-02-01 to 2021-10-31 | −$1.08 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-08-01 to 2021-10-31 | −$0.23 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2021-02-01 to 2021-10-31 | −$1.08 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-08-01 to 2021-10-31 | 531,718,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2021-02-01 to 2021-10-31 | 426,811,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2021-02-01 to 2021-10-31 | −$48.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-02-01 to 2021-10-31 | $5.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-10-31 | $1.78bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-10-31 | $2.21bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-10-31 | $2.47bn | us-gaap:Assets |
| Current liabilities | At period end2021-10-31 | $467.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-10-31 | $584.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-10-31 | $1.88bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001734722-21-000023. Last ingested by Listed: Nov 11, 2026, 00:25 ET. Listed shows no prices and gives no investment advice.